Covid-19 Impact on Global Pharmaceutical Contract Manufacturing and Contract Market Size, Status and Forecast 2020-2026

Covid-19 Impact on Global Pharmaceutical Contract Manufacturing and Contract Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pharmaceutical Contract Manufacturing and Contract Revenue
1.4 Market Analysis by Type
1.4.1 Global Pharmaceutical Contract Manufacturing and Contract Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oral
1.4.3 Injectable
1.4.4 API
1.4.5 Other
1.5 Market by Application
1.5.1 Global Pharmaceutical Contract Manufacturing and Contract Market Share by Application: 2020 VS 2026
1.5.2 Small Medium Enterprise
1.5.3 Large Enterprise
1.6 Coronavirus Disease 2019 (Covid-19): Pharmaceutical Contract Manufacturing and Contract Industry Impact
1.6.1 How the Covid-19 is Affecting the Pharmaceutical Contract Manufacturing and Contract Industry
1.6.1.1 Pharmaceutical Contract Manufacturing and Contract Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Pharmaceutical Contract Manufacturing and Contract Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Pharmaceutical Contract Manufacturing and Contract Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Pharmaceutical Contract Manufacturing and Contract Market Perspective (2015-2026)
2.2 Pharmaceutical Contract Manufacturing and Contract Growth Trends by Regions
2.2.1 Pharmaceutical Contract Manufacturing and Contract Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pharmaceutical Contract Manufacturing and Contract Historic Market Share by Regions (2015-2020)
2.2.3 Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Pharmaceutical Contract Manufacturing and Contract Market Growth Strategy
2.3.6 Primary Interviews with Key Pharmaceutical Contract Manufacturing and Contract Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Contract Manufacturing and Contract Players by Market Size
3.1.1 Global Top Pharmaceutical Contract Manufacturing and Contract Players by Revenue (2015-2020)
3.1.2 Global Pharmaceutical Contract Manufacturing and Contract Revenue Market Share by Players (2015-2020)
3.1.3 Global Pharmaceutical Contract Manufacturing and Contract Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pharmaceutical Contract Manufacturing and Contract Market Concentration Ratio
3.2.1 Global Pharmaceutical Contract Manufacturing and Contract Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pharmaceutical Contract Manufacturing and Contract Revenue in 2019
3.3 Pharmaceutical Contract Manufacturing and Contract Key Players Head office and Area Served
3.4 Key Players Pharmaceutical Contract Manufacturing and Contract Product Solution and Service
3.5 Date of Enter into Pharmaceutical Contract Manufacturing and Contract Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Pharmaceutical Contract Manufacturing and Contract Historic Market Size by Type (2015-2020)
4.2 Global Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Type (2021-2026)
5 Pharmaceutical Contract Manufacturing and Contract Breakdown Data by Application (2015-2026)
5.1 Global Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2015-2020)
5.2 Global Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Pharmaceutical Contract Manufacturing and Contract Market Size (2015-2020)
6.2 Pharmaceutical Contract Manufacturing and Contract Key Players in North America (2019-2020)
6.3 North America Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2015-2020)
6.4 North America Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2015-2020)
7 Europe
7.1 Europe Pharmaceutical Contract Manufacturing and Contract Market Size (2015-2020)
7.2 Pharmaceutical Contract Manufacturing and Contract Key Players in Europe (2019-2020)
7.3 Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2015-2020)
7.4 Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2015-2020)
8 China
8.1 China Pharmaceutical Contract Manufacturing and Contract Market Size (2015-2020)
8.2 Pharmaceutical Contract Manufacturing and Contract Key Players in China (2019-2020)
8.3 China Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2015-2020)
8.4 China Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2015-2020)
9 Japan
9.1 Japan Pharmaceutical Contract Manufacturing and Contract Market Size (2015-2020)
9.2 Pharmaceutical Contract Manufacturing and Contract Key Players in Japan (2019-2020)
9.3 Japan Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2015-2020)
9.4 Japan Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Pharmaceutical Contract Manufacturing and Contract Market Size (2015-2020)
10.2 Pharmaceutical Contract Manufacturing and Contract Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2015-2020)
10.4 Southeast Asia Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2015-2020)
11 India
11.1 India Pharmaceutical Contract Manufacturing and Contract Market Size (2015-2020)
11.2 Pharmaceutical Contract Manufacturing and Contract Key Players in India (2019-2020)
11.3 India Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2015-2020)
11.4 India Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2015-2020)
12 Key Players Profiles
12.1 Catalent
12.1.1 Catalent Company Details
12.1.2 Catalent Business Overview and Its Total Revenue
12.1.3 Catalent Pharmaceutical Contract Manufacturing and Contract Introduction
12.1.4 Catalent Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020))
12.1.5 Catalent Recent Development
12.2 Thermo Fisher Scientific
12.2.1 Thermo Fisher Scientific Company Details
12.2.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
12.2.3 Thermo Fisher Scientific Pharmaceutical Contract Manufacturing and Contract Introduction
12.2.4 Thermo Fisher Scientific Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
12.2.5 Thermo Fisher Scientific Recent Development
12.3 Lonza
12.3.1 Lonza Company Details
12.3.2 Lonza Business Overview and Its Total Revenue
12.3.3 Lonza Pharmaceutical Contract Manufacturing and Contract Introduction
12.3.4 Lonza Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
12.3.5 Lonza Recent Development
12.4 Boehringer Ingelheim
12.4.1 Boehringer Ingelheim Company Details
12.4.2 Boehringer Ingelheim Business Overview and Its Total Revenue
12.4.3 Boehringer Ingelheim Pharmaceutical Contract Manufacturing and Contract Introduction
12.4.4 Boehringer Ingelheim Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
12.4.5 Boehringer Ingelheim Recent Development
12.5 Fareva
12.5.1 Fareva Company Details
12.5.2 Fareva Business Overview and Its Total Revenue
12.5.3 Fareva Pharmaceutical Contract Manufacturing and Contract Introduction
12.5.4 Fareva Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
12.5.5 Fareva Recent Development
12.6 Recipharm
12.6.1 Recipharm Company Details
12.6.2 Recipharm Business Overview and Its Total Revenue
12.6.3 Recipharm Pharmaceutical Contract Manufacturing and Contract Introduction
12.6.4 Recipharm Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
12.6.5 Recipharm Recent Development
12.7 Aenova
12.7.1 Aenova Company Details
12.7.2 Aenova Business Overview and Its Total Revenue
12.7.3 Aenova Pharmaceutical Contract Manufacturing and Contract Introduction
12.7.4 Aenova Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
12.7.5 Aenova Recent Development
12.8 AbbVie
12.8.1 AbbVie Company Details
12.8.2 AbbVie Business Overview and Its Total Revenue
12.8.3 AbbVie Pharmaceutical Contract Manufacturing and Contract Introduction
12.8.4 AbbVie Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
12.8.5 AbbVie Recent Development
12.9 Baxter
12.9.1 Baxter Company Details
12.9.2 Baxter Business Overview and Its Total Revenue
12.9.3 Baxter Pharmaceutical Contract Manufacturing and Contract Introduction
12.9.4 Baxter Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
12.9.5 Baxter Recent Development
12.10 Nipro Corp
12.10.1 Nipro Corp Company Details
12.10.2 Nipro Corp Business Overview and Its Total Revenue
12.10.3 Nipro Corp Pharmaceutical Contract Manufacturing and Contract Introduction
12.10.4 Nipro Corp Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
12.10.5 Nipro Corp Recent Development
12.11 Sopharma
10.11.1 Sopharma Company Details
10.11.2 Sopharma Business Overview and Its Total Revenue
10.11.3 Sopharma Pharmaceutical Contract Manufacturing and Contract Introduction
10.11.4 Sopharma Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
10.11.5 Sopharma Recent Development
12.12 Famar
10.12.1 Famar Company Details
10.12.2 Famar Business Overview and Its Total Revenue
10.12.3 Famar Pharmaceutical Contract Manufacturing and Contract Introduction
10.12.4 Famar Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
10.12.5 Famar Recent Development
12.13 Vetter
10.13.1 Vetter Company Details
10.13.2 Vetter Business Overview and Its Total Revenue
10.13.3 Vetter Pharmaceutical Contract Manufacturing and Contract Introduction
10.13.4 Vetter Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
10.13.5 Vetter Recent Development
12.14 Shandong Xinhua
10.14.1 Shandong Xinhua Company Details
10.14.2 Shandong Xinhua Business Overview and Its Total Revenue
10.14.3 Shandong Xinhua Pharmaceutical Contract Manufacturing and Contract Introduction
10.14.4 Shandong Xinhua Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
10.14.5 Shandong Xinhua Recent Development
12.15 Piramal
10.15.1 Piramal Company Details
10.15.2 Piramal Business Overview and Its Total Revenue
10.15.3 Piramal Pharmaceutical Contract Manufacturing and Contract Introduction
10.15.4 Piramal Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
10.15.5 Piramal Recent Development
12.16 Mylan
10.16.1 Mylan Company Details
10.16.2 Mylan Business Overview and Its Total Revenue
10.16.3 Mylan Pharmaceutical Contract Manufacturing and Contract Introduction
10.16.4 Mylan Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
10.16.5 Mylan Recent Development
12.17 Dr. Reddy's
10.17.1 Dr. Reddy's Company Details
10.17.2 Dr. Reddy's Business Overview and Its Total Revenue
10.17.3 Dr. Reddy's Pharmaceutical Contract Manufacturing and Contract Introduction
10.17.4 Dr. Reddy's Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
10.17.5 Dr. Reddy's Recent Development
12.18 Zhejiang Hisun
10.18.1 Zhejiang Hisun Company Details
10.18.2 Zhejiang Hisun Business Overview and Its Total Revenue
10.18.3 Zhejiang Hisun Pharmaceutical Contract Manufacturing and Contract Introduction
10.18.4 Zhejiang Hisun Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
10.18.5 Zhejiang Hisun Recent Development
12.19 Zhejiang Huahai
10.19.1 Zhejiang Huahai Company Details
10.19.2 Zhejiang Huahai Business Overview and Its Total Revenue
10.19.3 Zhejiang Huahai Pharmaceutical Contract Manufacturing and Contract Introduction
10.19.4 Zhejiang Huahai Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
10.19.5 Zhejiang Huahai Recent Development
12.20 Jubilant
10.20.1 Jubilant Company Details
10.20.2 Jubilant Business Overview and Its Total Revenue
10.20.3 Jubilant Pharmaceutical Contract Manufacturing and Contract Introduction
10.20.4 Jubilant Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
10.20.5 Jubilant Recent Development
13 Analyst's Viewpoints/Conclusions
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer
14.3 Author Details
List of Tables
Table 1. Pharmaceutical Contract Manufacturing and Contract Key Market Segments
Table 2. Key Players Covered: Ranking by Pharmaceutical Contract Manufacturing and Contract Revenue
Table 3. Ranking of Global Top Pharmaceutical Contract Manufacturing and Contract Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pharmaceutical Contract Manufacturing and Contract Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral
Table 6. Key Players of Injectable
Table 7. Key Players of API
Table 8. Key Players of Other
Table 9. COVID-19 Impact Global Market: (Four Pharmaceutical Contract Manufacturing and Contract Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Pharmaceutical Contract Manufacturing and Contract Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Pharmaceutical Contract Manufacturing and Contract Players to Combat Covid-19 Impact
Table 14. Global Pharmaceutical Contract Manufacturing and Contract Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Pharmaceutical Contract Manufacturing and Contract Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Pharmaceutical Contract Manufacturing and Contract Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Regions (2015-2020)
Table 18. Global Pharmaceutical Contract Manufacturing and Contract Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Pharmaceutical Contract Manufacturing and Contract Market Growth Strategy
Table 24. Main Points Interviewed from Key Pharmaceutical Contract Manufacturing and Contract Players
Table 25. Global Pharmaceutical Contract Manufacturing and Contract Revenue by Players (2015-2020) (Million US$)
Table 26. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Players (2015-2020)
Table 27. Global Top Pharmaceutical Contract Manufacturing and Contract Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Contract Manufacturing and Contract as of 2019)
Table 28. Global Pharmaceutical Contract Manufacturing and Contract by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Pharmaceutical Contract Manufacturing and Contract Product Solution and Service
Table 31. Date of Enter into Pharmaceutical Contract Manufacturing and Contract Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2015-2020) (Million US$)
Table 34. Global Pharmaceutical Contract Manufacturing and Contract Market Size Share by Type (2015-2020)
Table 35. Global Pharmaceutical Contract Manufacturing and Contract Revenue Market Share by Type (2021-2026)
Table 36. Global Pharmaceutical Contract Manufacturing and Contract Market Size Share by Application (2015-2020)
Table 37. Global Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2015-2020) (Million US$)
Table 38. Global Pharmaceutical Contract Manufacturing and Contract Market Size Share by Application (2021-2026)
Table 39. North America Key Players Pharmaceutical Contract Manufacturing and Contract Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Pharmaceutical Contract Manufacturing and Contract Market Share (2019-2020)
Table 41. North America Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2015-2020) (Million US$)
Table 42. North America Pharmaceutical Contract Manufacturing and Contract Market Share by Type (2015-2020)
Table 43. North America Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2015-2020) (Million US$)
Table 44. North America Pharmaceutical Contract Manufacturing and Contract Market Share by Application (2015-2020)
Table 45. Europe Key Players Pharmaceutical Contract Manufacturing and Contract Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Pharmaceutical Contract Manufacturing and Contract Market Share (2019-2020)
Table 47. Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Pharmaceutical Contract Manufacturing and Contract Market Share by Type (2015-2020)
Table 49. Europe Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Pharmaceutical Contract Manufacturing and Contract Market Share by Application (2015-2020)
Table 51. China Key Players Pharmaceutical Contract Manufacturing and Contract Revenue (2019-2020) (Million US$)
Table 52. China Key Players Pharmaceutical Contract Manufacturing and Contract Market Share (2019-2020)
Table 53. China Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2015-2020) (Million US$)
Table 54. China Pharmaceutical Contract Manufacturing and Contract Market Share by Type (2015-2020)
Table 55. China Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2015-2020) (Million US$)
Table 56. China Pharmaceutical Contract Manufacturing and Contract Market Share by Application (2015-2020)
Table 57. Japan Key Players Pharmaceutical Contract Manufacturing and Contract Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Pharmaceutical Contract Manufacturing and Contract Market Share (2019-2020)
Table 59. Japan Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Pharmaceutical Contract Manufacturing and Contract Market Share by Type (2015-2020)
Table 61. Japan Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Pharmaceutical Contract Manufacturing and Contract Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Pharmaceutical Contract Manufacturing and Contract Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Pharmaceutical Contract Manufacturing and Contract Market Share (2019-2020)
Table 65. Southeast Asia Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Pharmaceutical Contract Manufacturing and Contract Market Share by Type (2015-2020)
Table 67. Southeast Asia Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Pharmaceutical Contract Manufacturing and Contract Market Share by Application (2015-2020)
Table 69. India Key Players Pharmaceutical Contract Manufacturing and Contract Revenue (2019-2020) (Million US$)
Table 70. India Key Players Pharmaceutical Contract Manufacturing and Contract Market Share (2019-2020)
Table 71. India Pharmaceutical Contract Manufacturing and Contract Market Size by Type (2015-2020) (Million US$)
Table 72. India Pharmaceutical Contract Manufacturing and Contract Market Share by Type (2015-2020)
Table 73. India Pharmaceutical Contract Manufacturing and Contract Market Size by Application (2015-2020) (Million US$)
Table 74. India Pharmaceutical Contract Manufacturing and Contract Market Share by Application (2015-2020)
Table 75. Catalent Company Details
Table 76. Catalent Business Overview
Table 77. Catalent Product
Table 78. Catalent Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020) (Million US$)
Table 79. Catalent Recent Development
Table 80. Thermo Fisher Scientific Company Details
Table 81. Thermo Fisher Scientific Business Overview
Table 82. Thermo Fisher Scientific Product
Table 83. Thermo Fisher Scientific Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020) (Million US$)
Table 84. Thermo Fisher Scientific Recent Development
Table 85. Lonza Company Details
Table 86. Lonza Business Overview
Table 87. Lonza Product
Table 88. Lonza Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020) (Million US$)
Table 89. Lonza Recent Development
Table 90. Boehringer Ingelheim Company Details
Table 91. Boehringer Ingelheim Business Overview
Table 92. Boehringer Ingelheim Product
Table 93. Boehringer Ingelheim Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020) (Million US$)
Table 94. Boehringer Ingelheim Recent Development
Table 95. Fareva Company Details
Table 96. Fareva Business Overview
Table 97. Fareva Product
Table 98. Fareva Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020) (Million US$)
Table 99. Fareva Recent Development
Table 100. Recipharm Company Details
Table 101. Recipharm Business Overview
Table 102. Recipharm Product
Table 103. Recipharm Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020) (Million US$)
Table 104. Recipharm Recent Development
Table 105. Aenova Company Details
Table 106. Aenova Business Overview
Table 107. Aenova Product
Table 108. Aenova Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020) (Million US$)
Table 109. Aenova Recent Development
Table 110. AbbVie Business Overview
Table 111. AbbVie Product
Table 112. AbbVie Company Details
Table 113. AbbVie Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020) (Million US$)
Table 114. AbbVie Recent Development
Table 115. Baxter Company Details
Table 116. Baxter Business Overview
Table 117. Baxter Product
Table 118. Baxter Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020) (Million US$)
Table 119. Baxter Recent Development
Table 120. Nipro Corp Company Details
Table 121. Nipro Corp Business Overview
Table 122. Nipro Corp Product
Table 123. Nipro Corp Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020) (Million US$)
Table 124. Nipro Corp Recent Development
Table 125. Sopharma Company Details
Table 126. Sopharma Business Overview
Table 127. Sopharma Product
Table 128. Sopharma Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020) (Million US$)
Table 129. Sopharma Recent Development
Table 130. Famar Company Details
Table 131. Famar Business Overview
Table 132. Famar Product
Table 133. Famar Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020) (Million US$)
Table 134. Famar Recent Development
Table 135. Vetter Company Details
Table 136. Vetter Business Overview
Table 137. Vetter Product
Table 138. Vetter Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020) (Million US$)
Table 139. Vetter Recent Development
Table 140. Shandong Xinhua Company Details
Table 141. Shandong Xinhua Business Overview
Table 142. Shandong Xinhua Product
Table 143. Shandong Xinhua Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020) (Million US$)
Table 144. Shandong Xinhua Recent Development
Table 145. Piramal Company Details
Table 146. Piramal Business Overview
Table 147. Piramal Product
Table 148. Piramal Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020) (Million US$)
Table 149. Piramal Recent Development
Table 150. Mylan Company Details
Table 151. Mylan Business Overview
Table 152. Mylan Product
Table 153. Mylan Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020) (Million US$)
Table 154. Mylan Recent Development
Table 155. Dr. Reddy's Company Details
Table 156. Dr. Reddy's Business Overview
Table 157. Dr. Reddy's Product
Table 158. Dr. Reddy's Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020) (Million US$)
Table 159. Dr. Reddy's Recent Development
Table 160. Zhejiang Hisun Company Details
Table 161. Zhejiang Hisun Business Overview
Table 162. Zhejiang Hisun Product
Table 163. Zhejiang Hisun Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020) (Million US$)
Table 164. Zhejiang Hisun Recent Development
Table 165. Zhejiang Huahai Company Details
Table 166. Zhejiang Huahai Business Overview
Table 167. Zhejiang Huahai Product
Table 168. Zhejiang Huahai Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020) (Million US$)
Table 169. Zhejiang Huahai Recent Development
Table 170. Jubilant Company Details
Table 171. Jubilant Business Overview
Table 172. Jubilant Product
Table 173. Jubilant Revenue in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020) (Million US$)
Table 174. Jubilant Recent Development
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Type: 2020 VS 2026
Figure 2. Oral Features
Figure 3. Injectable Features
Figure 4. API Features
Figure 5. Other Features
Figure 6. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Application: 2020 VS 2026
Figure 7. Small Medium Enterprise Case Studies
Figure 8. Large Enterprise Case Studies
Figure 9. Pharmaceutical Contract Manufacturing and Contract Report Years Considered
Figure 10. Global Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Regions: 2020 VS 2026
Figure 12. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Pharmaceutical Contract Manufacturing and Contract Market Share by Players in 2019
Figure 15. Global Top Pharmaceutical Contract Manufacturing and Contract Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Contract Manufacturing and Contract as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Pharmaceutical Contract Manufacturing and Contract Revenue in 2019
Figure 17. North America Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Pharmaceutical Contract Manufacturing and Contract Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Catalent Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Catalent Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
Figure 25. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Thermo Fisher Scientific Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
Figure 27. Lonza Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Lonza Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
Figure 29. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Boehringer Ingelheim Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
Figure 31. Fareva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Fareva Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
Figure 33. Recipharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Recipharm Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
Figure 35. Aenova Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Aenova Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
Figure 37. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. AbbVie Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
Figure 39. Baxter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Baxter Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
Figure 41. Nipro Corp Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Nipro Corp Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
Figure 43. Sopharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Sopharma Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
Figure 45. Famar Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Famar Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
Figure 47. Vetter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Vetter Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
Figure 49. Shandong Xinhua Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Shandong Xinhua Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
Figure 51. Piramal Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Piramal Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
Figure 53. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Mylan Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
Figure 55. Dr. Reddy's Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Dr. Reddy's Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
Figure 57. Zhejiang Hisun Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Zhejiang Hisun Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
Figure 59. Zhejiang Huahai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Zhejiang Huahai Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
Figure 61. Jubilant Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Jubilant Revenue Growth Rate in Pharmaceutical Contract Manufacturing and Contract Business (2015-2020)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs